Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer’s disease (AD).
Boundless Bio seeks $88M in IPO as it runs two Ph1 cancer trials
The spring IPO class is here. Boundless Bio, a cancer biotech with two different oral small molecules in Phase 1 testing, eyes about $88.4 million